Details for Patent: 11,612,658
✉ Email this page to a colleague
Which drugs does patent 11,612,658 protect, and when does it expire?
Patent 11,612,658 protects VERKAZIA and is included in one NDA.
This patent has forty-four patent family members in eighteen countries.
Summary for Patent: 11,612,658
| Title: | Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same |
| Abstract: | Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions. |
| Inventor(s): | Laura Rabinovich-Guilatt, Gregory Lambert, Frederic LALLEMAND, Betty Philips |
| Assignee: | Novagali SA , Santen SAS |
| Application Number: | US16/949,237 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Device; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 11,612,658
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN AND ADULTS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,612,658
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2049079 | ⤷ Start Trial | PA2017003 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2049079 | ⤷ Start Trial | LUC00006 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2049079 | ⤷ Start Trial | PA2017003,C2049079 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2049079 | ⤷ Start Trial | 201740003 | Slovenia | ⤷ Start Trial |
| Australia | 2007278141 | ⤷ Start Trial | |||
| Canada | 2659322 | ⤷ Start Trial | |||
| China | 101534791 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
